Left Atrial Size and Ischemic Events after Ischemic Stroke or Transient Ischemic Attack in Patients with Nonvalvular Atrial Fibrillation.


Journal

Cerebrovascular diseases (Basel, Switzerland)
ISSN: 1421-9786
Titre abrégé: Cerebrovasc Dis
Pays: Switzerland
ID NLM: 9100851

Informations de publication

Date de publication:
2020
Historique:
received: 10 05 2020
accepted: 01 09 2020
pubmed: 12 11 2020
medline: 30 3 2021
entrez: 11 11 2020
Statut: ppublish

Résumé

The present study aimed to clarify the association between left atrial (LA) size and ischemic events after ischemic stroke or transient ischemic attack (TIA) in patients with nonvalvular atrial fibrillation (NVAF). Acute ischemic stroke or TIA patients with NVAF were enrolled. LA size was classified into normal LA size, mild LA enlargement (LAE), moderate LAE, and severe LAE. The ischemic event was defined as ischemic stroke, TIA, carotid endarterectomy, carotid artery stenting, acute coronary syndrome or percutaneous coronary intervention, systemic embolism, aortic aneurysm rupture or dissection, peripheral artery disease requiring hospitalization, or venous thromboembolism. A total of 1,043 patients (mean age, 78 years; 450 women) including 1,002 ischemic stroke and 41 TIA were analyzed. Of these, 351 patients (34%) had normal LA size, 298 (29%) had mild LAE, 198 (19%) had moderate LAE, and the remaining 196 (19%) had severe LAE. The median follow-up duration was 2.0 years (interquartile range, 0.9-2.1). During follow-up, 117 patients (11%) developed at least one ischemic event. The incidence rate of total ischemic events increased with increasing LA size. Severe LAE was independently associated with increased risk of ischemic events compared with normal LA size (multivariable-adjusted hazard ratio, 1.75; 95% confidence interval, 1.02-3.00). Severe LAE was associated with increased risk of ischemic events after ischemic stroke or TIA in patients with NVAF.

Sections du résumé

BACKGROUND
The present study aimed to clarify the association between left atrial (LA) size and ischemic events after ischemic stroke or transient ischemic attack (TIA) in patients with nonvalvular atrial fibrillation (NVAF).
METHODS
Acute ischemic stroke or TIA patients with NVAF were enrolled. LA size was classified into normal LA size, mild LA enlargement (LAE), moderate LAE, and severe LAE. The ischemic event was defined as ischemic stroke, TIA, carotid endarterectomy, carotid artery stenting, acute coronary syndrome or percutaneous coronary intervention, systemic embolism, aortic aneurysm rupture or dissection, peripheral artery disease requiring hospitalization, or venous thromboembolism.
RESULTS
A total of 1,043 patients (mean age, 78 years; 450 women) including 1,002 ischemic stroke and 41 TIA were analyzed. Of these, 351 patients (34%) had normal LA size, 298 (29%) had mild LAE, 198 (19%) had moderate LAE, and the remaining 196 (19%) had severe LAE. The median follow-up duration was 2.0 years (interquartile range, 0.9-2.1). During follow-up, 117 patients (11%) developed at least one ischemic event. The incidence rate of total ischemic events increased with increasing LA size. Severe LAE was independently associated with increased risk of ischemic events compared with normal LA size (multivariable-adjusted hazard ratio, 1.75; 95% confidence interval, 1.02-3.00).
CONCLUSION
Severe LAE was associated with increased risk of ischemic events after ischemic stroke or TIA in patients with NVAF.

Identifiants

pubmed: 33176314
pii: 000511393
doi: 10.1159/000511393
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

619-624

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Keisuke Tokunaga (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan, keisuketokunaga@hotmail.co.jp.

Masatoshi Koga (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Sohei Yoshimura (S)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Yasushi Okada (Y)

Department of Neurology and Cerebrovascular Medicine, NHO Kyushu Medical Center, Fukuoka, Japan.

Hiroshi Yamagami (H)

Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan.

Kenichi Todo (K)

Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.

Ryo Itabashi (R)

Department of Stroke Neurology, Kohnan Hospital, Sendai, Japan.

Kazumi Kimura (K)

Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Shoichiro Sato (S)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Tadashi Terasaki (T)

Department of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.

Manabu Inoue (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshiaki Shiokawa (Y)

Departments of Neurosurgery and Stroke Center, Kyorin University School of Medicine, Mitaka, Japan.

Masahito Takagi (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Kenji Kamiyama (K)

Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Japan.

Kanta Tanaka (K)

Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan.

Shunya Takizawa (S)

Department of Neurology, Tokai University School of Medicine, Isehara, Japan.

Masayuki Shiozawa (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Okuda (S)

Department of Neurology, NHO Nagoya Medical Center, Nagoya, Japan.

Tomoaki Kameda (T)

Division of Neurology, Jichi Medical University School of Medicine, Shimotsuke, Japan.

Yoshinari Nagakane (Y)

Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.

Yasuhiro Hasegawa (Y)

Department of Neurology, St. Marianna University School of Medicine, Kawasaki, Japan.

Satoshi Shibuya (S)

Department of Neurology, South Miyagi Medical Center, Ogawara, Japan.

Yasuhiro Ito (Y)

Department of Neurology, TOYOTA Memorial Hospital, Toyota, Japan.

Hideki Matsuoka (H)

Department of Cerebrovascular Medicine, NHO Kagoshima Medical Center, Kagoshima, Japan.

Kazuhiro Takamatsu (K)

Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Japan.

Kazutoshi Nishiyama (K)

Department of Neurology, Kitasato University School of Medicine, Sagamihara, Japan.

Kazuomi Kario (K)

Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.

Yoshiki Yagita (Y)

Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.

Tadataka Mizoguchi (T)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Kyohei Fujita (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Daisuke Ando (D)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Masaya Kumamoto (M)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Kaori Miwa (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Shoji Arihiro (S)

Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan.

Kazunori Toyoda (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH